Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU research fights killer viruses’ stubborn resistance to drugs

29.06.2004


Viruses’ growing resistance to drugs means diseases such as hepatitis B and C are increasingly difficult to treat. New pandemics may arise with unforeseeable consequences. The EU is therefore contributing € 9 million to the “Vigilance against Viral Resistance” (VIRGIL) project, to be launched today in Lyon (France). It will start by addressing drug resistance in viral hepatitis and influenza, but will broaden its scope to other viruses. The network will be based on research and technological platforms to monitor existing, and anticipate future, drug resistance. One platform will monitor, test and improve the management of antiviral drug resistance in patients while another will show how resistance occurs and help understand patient-related (immune/genetic) factors causing viral resistance. Other platforms for drugs and pharmacology and for innovation and technology will allow anticipation of ways to rapidly overcome drug resistance. Finally, a societal impact platform will assess the network’s benefit for medicine and patients’ quality of life. VIRGIL, coordinated by Lyon’s INSERM research centre, will gather 55 key European field experts from 12 countries, including 7 partners from industry.

“The heavy use of antibiotics, particularly in hospitals, hastens mutations in bacteria which bring about drug resistance. The same happens in viruses when antiviral drugs are used extensively,” European Research Commissioner Philippe Busquin said. “VIRGIL complements a €30 million EU research investment into antimicrobial drug resistance over the past two years to address this growing problem. Through collaboration between European academic researchers, the pharmaceutical industry, clinicians and public health authorities the network will help overcome problems associated with viral drug resistance to help save lives.”

Killer diseases: on the rampage?



Viral hepatitis causes chronic liver disease, including cirrhosis and liver cancer. Although a safe and efficient vaccine does exist for hepatitis B, over 350 million people around the world are now chronically infected with this virus. For hepatitis C, no vaccine exists and over 1% of Europeans are carriers. Intensive clinical use of the few available drugs has led to rapidly emerging drug resistance for some viruses so that these drugs are no longer efficient.

Yearly epidemics of new flu strains infect 5-15% of the world population with up to 500.000 deaths. Genetic changes in the influenza virus may lead to severe epidemics of global dimension (pandemics), such as the Spanish flu of 1918 that killed over 40 million people. Experts now fear another pandemic may arise shortly with unforeseeable consequences. Access to efficient drugs will be essential in such a catastrophic scenario. Again, the virus is likely to develop drug resistance.

EU research saves lives and money

The VIRGIL network will be able to rapidly and reliably determine resistance to new drugs and the drug susceptibility of emerging viral strains based on new treatments. The network aims to link up with the antiviral drug producing pharmaceutical industry in a cost-effective partnership that will help to ensure longer access to treatment and cure for the patients. This will help contain the socio-economic burden of viral resistance, now representing a major health problem with higher health care and drug development costs.

Fabio Fabbi | EU Commission
Further information:
http://www.europa.eu.int
http://www.virgil-net.org

More articles from Agricultural and Forestry Science:

nachricht New insight into why Pierce's disease is so deadly to grapevines
11.06.2018 | University of California - Davis

nachricht Where are Europe’s last primary forests?
29.05.2018 | Humboldt-Universität zu Berlin

All articles from Agricultural and Forestry Science >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

Im Focus: Photoexcited graphene puzzle solved

A boost for graphene-based light detectors

Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Carbon nanotube optics provide optical-based quantum cryptography and quantum computing

19.06.2018 | Physics and Astronomy

How to track and trace a protein: Nanosensors monitor intracellular deliveries

19.06.2018 | Life Sciences

New material for splitting water

19.06.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>